[1]王 娟.疏血通联合马来酸桂哌齐特治疗视网膜中央动脉阻塞的 疗效观察[J].医学信息,2018,31(06):120-122.[doi:10.3969/j.issn.1006-1959.2018.06.040]
　WANG Juan.Clinical Observation of Shuxuetong Combined with Cinepazide Maleate in the Treatment of Central Retinal Artery Occlusion[J].Journal of Medical Information,2018,31(06):120-122.[doi:10.3969/j.issn.1006-1959.2018.06.040]
点击复制

疏血通联合马来酸桂哌齐特治疗视网膜中央动脉阻塞的 疗效观察()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年06期
页码:
120-122
栏目:
药物与临床
出版日期:
2018-03-20

文章信息/Info

Title:
Clinical Observation of Shuxuetong Combined with Cinepazide Maleate in the Treatment of Central Retinal Artery Occlusion
文章编号:
1006-1959（2018）06-0120-03
作者:
王 娟
天津市静海区医院眼科，天津 301600
Author(s):
WANG Juan
Department of Ophthalmology,Jinghai District Hospital,Tianjin 301600,China
关键词:
视网膜中央动脉阻塞; 疏血通注射液;  马来酸桂哌齐特注射液
Keywords:
Key words：Central retinal artery occlusion; Shuxuetong injection; Cinepazide maleate injection
分类号:
R774
DOI:
10.3969/j.issn.1006-1959.2018.06.040
文献标志码:
A
摘要:
目的 观察疏血通注射液联合马来酸桂哌齐特注射液治疗视网膜中央动脉阻塞的疗效。方法 本研究回顾性分析天津市静海区医院2012年12月~2017年2月收治的31例（31眼）CRAO患者的病历资料，所有患者均给予疏血通注射液联合马来酸桂哌齐特注射液等药物治疗，分析治疗1疗程（14 d）后视力恢复情况。结果 31眼CRAO中治愈3眼，显效7眼，有效17眼，无效4眼，总有效率87.10%。结论 疏血通具有抗凝、溶栓、清除自由基、减轻组织缺血/再灌注损伤的作用，马来酸桂哌齐特可缓解血管痉挛、降低血管阻力、增加血流量、降低氧耗，二者联合应用治疗CRAO疗效显著。
Abstract:
Abstract：Objective To observe the effect of Shuxuetong injection combined with cinepazide maleate injection on central retinal artery occlusion.Methods This was a retrospective study of Tianjin District of Jinghai city hospital in December 2012~2017 year in February 31 cases(31 eyes)of CRAO patients,all patients were given Shuxuetong injection combined with Cinepazide maleate injection and other drugs,analysis of 1 courses of treatment(14 d)after recovery.Results CRAO in 31 eyes of 3 eyes were cured,markedly effective in 7 eyes,17 eyes were effective,4 eyes were invalid,the total efficiency of 87.10%.Conclusion Shuxuetong has anticoagulation and thrombolysis,free radical scavenging, alleviate the ischemia/reperfusion injury,cinepazide maleate can relieve vascular spasm,reduce vascular resistance and increase blood flow,reduce the oxygen consumption, the combination of the two significant effect in treating CRAO.

参考文献/References:

[1]Biousse V.Thrombolysis for acute central retinal artery occlusion: is it time[J].American Journal of Ophthalmology,2008,146(5):631-634. [2]王润生,钱路,王毅,等.眼动脉分支逆行介入溶栓治疗视网膜中央动脉阻塞疗效观察[J].中华眼底病杂志,2016,32(4):377-381. [3]徐海龙,李勇.复方樟柳碱联合血栓通及葛根素治疗CRAO的疗效[J].国际眼科杂志,2012,12(10):2002-2003. [4]仲浩,吴德芹.马来酸桂哌齐特注射液治疗急性脑梗死的临床疗效及安全性[J].临床合理用药杂志,2017,10(24):8-9. [5]王亚丽,韩敬,曹颖.马来酸桂哌齐特治疗椎基底动脉供血不足患者的临床疗效及安全性[J].中国药物经济学,2016,11(3):90-91. [6]姚波,孙玉敏,武学伟,等.疏血通注射液联合桂哌齐特治疗短暂性脑缺血发作的疗效观察[J].现代药物与临床,2016,31(10):1595-1598. [7]刘云海,方淑贤.疏血通注射液[J].医药导报,2002,21(6):378-379. [8]王海峰.疏血通联合依达拉奉治疗糖尿病视网膜病变临床分析[J].中国现代药物应用,2010,4(4):159. [9]刘洁,郭莉莉,代洪辉,等.疏血通治疗糖尿病视网膜病变疗效观察[J].中国现代药物应用,2010,4(4):109-110. [10]刘斌,王鹏琴.眼针与疏血通注射液结合治疗中风后眼肌麻痹74例[J].内蒙古中医药，2014,33(31):61-62.

相似文献/References:

[1]白 璐.辅助应用疏血通注射液对急性心肌梗死患者凝血指标及心电图变化的影响[J].医学信息,2022,35(02):172.[doi:10.3969/j.issn.1006-1959.2022.02.045]
　BAI Lu.Effect of Shuxuetong Injection on Coagulation Index and Electrocardiogram Changesin Patients with Acute Myocardial Infarction[J].Journal of Medical Information,2022,35(06):172.[doi:10.3969/j.issn.1006-1959.2022.02.045]

更新日期/Last Update: 2018-03-15